Oncternal Therapeutics (ONCT) Short Interest Ratio & Short Volume

$8.55
-0.31 (-3.50%)
(As of 04/22/2024 ET)

Oncternal Therapeutics Short Interest Data

Current Short Volume
16,700 shares
Previous Short Volume
15,000 shares
Change Vs. Previous Month
+11.33%
Dollar Volume Sold Short
$150,300.00
Short Interest Ratio / Days to Cover
1.3
Last Record Date
March 31, 2024
Outstanding Shares
2,690,000 shares
Float Size
2,670,000 shares
Short Percent of Float
0.63%
Today's Trading Volume
1,657 shares
Average Trading Volume
12,267 shares
Today's Volume Vs. Average
14%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Oncternal Therapeutics ?

Sign up to receive the latest short interest report for Oncternal Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ONCT Short Interest Over Time

ONCT Days to Cover Over Time

ONCT Percentage of Float Shorted Over Time

Oncternal Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/202416,700 shares $150,300.00 +11.3%0.6%1.3 $9.00
3/15/202415,000 shares $120,300.00 -6.3%0.6%1 $8.02
2/29/202416,000 shares $148,800.00 -28.3%0.6%0.9 $9.30
2/15/202422,300 shares $200,477.00 -10.8%0.8%1.3 $8.99
1/31/202425,000 shares $244,250.00 +25.0%0.9%1.5 $9.77
1/15/202420,000 shares $171,800.00 +52.7%0.8%1.2 $8.59
12/31/202313,100 shares $140,484.40 -94.6%0.4%0.9 $10.72
12/15/2023241,400 shares $91,732.00 -22.1%N/A1 $0.38
11/30/2023310,000 shares $114,080.00 -28.6%N/A1.7 $0.37
11/15/2023433,900 shares $140,974.11 +5.5%N/A2.9 $0.32
10/31/2023411,200 shares $139,561.28 +46.7%N/A2.5 $0.34
10/15/2023280,300 shares $82,688.50 +2.1%N/A1.7 $0.30
9/30/2023274,500 shares $82,350.00 -8.0%N/A1.4 $0.30
9/15/2023298,300 shares $104,405.00 +0.6%N/A1.4 $0.35
8/31/2023296,500 shares $88,950.00 -7.6%N/A1.2 $0.30
8/15/2023320,900 shares $120,979.30 -6.4%N/A1.2 $0.38
7/31/2023342,700 shares $126,901.81 -23.6%N/A1.3 $0.37
7/15/2023448,600 shares $205,593.38 +32.8%N/A1.7 $0.46
6/30/2023337,700 shares $116,506.50 -4.0%N/A0.9 $0.35
6/15/2023351,600 shares $140,640.00 +27.4%N/A0.6 $0.40
5/31/2023276,100 shares $78,688.50 +7.4%N/A0.5 $0.29
5/15/2023257,000 shares $75,815.00 -46.6%N/A0.5 $0.30
4/30/2023480,900 shares $147,395.85 -1.9%N/A0.9 $0.31
4/15/2023490,300 shares $153,120.69 +29.0%N/A1 $0.31
3/31/2023380,000 shares $298,300.00 -8.0%N/A0.8 $0.79
3/15/2023412,900 shares $300,426.04 +1.8%N/A1.8 $0.73
2/28/2023405,600 shares $361,632.96 -2.1%N/A1.5 $0.89
2/15/2023414,200 shares $426,626.00 -5.6%N/A1.6 $1.03
1/31/2023438,600 shares $491,232.00 -34.3%N/A1.6 $1.12
1/15/2023667,600 shares $861,204.00 -29.7%N/A2.4 $1.29
12/30/2022950,000 shares $950,000.00 +0.2%N/A3.4 $1.00
12/15/2022947,800 shares $871,976.00 +61.3%N/A3.4 $0.92
11/30/2022587,700 shares $534,865.77 -18.2%N/A2.1 $0.91
11/15/2022718,800 shares $725,988.00 +28.0%N/A2.8 $1.01
10/31/2022561,400 shares $589,470.00 -15.6%N/A1.7 $1.05
10/15/2022665,300 shares $725,177.00 -52.1%N/A1.8 $1.09
9/30/20221,390,000 shares $1.24 million +70.0%N/A3.3 $0.89
9/15/2022817,800 shares $801,525.78 +38.2%1.7%1.6 $0.98
8/31/2022591,800 shares $662,816.00 +7.4%1.3%1.1 $1.12
8/15/2022551,100 shares $677,853.00 -16.3%1.3%0.5 $1.23
SHOCKING Crypto Leak… (Ad)

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

ONCT Short Interest - Frequently Asked Questions

What is Oncternal Therapeutics' current short interest?

Short interest is the volume of Oncternal Therapeutics shares that have been sold short but have not yet been covered or closed out. As of March 31st, traders have sold 16,700 shares of ONCT short. 0.63% of Oncternal Therapeutics' shares are currently sold short. Learn More on Oncternal Therapeutics' current short interest.

What is a good short interest ratio for Oncternal Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ONCT shares currently have a short interest ratio of 1.0. Learn More on Oncternal Therapeutics's short interest ratio.

What is a good short interest percentage for Oncternal Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.63% of Oncternal Therapeutics' floating shares are currently sold short.

Is Oncternal Therapeutics' short interest increasing or decreasing?

Oncternal Therapeutics saw a increase in short interest in March. As of March 31st, there was short interest totaling 16,700 shares, an increase of 11.3% from the previous total of 15,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Oncternal Therapeutics' float size?

Oncternal Therapeutics currently has issued a total of 2,690,000 shares. Some of Oncternal Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Oncternal Therapeutics currently has a public float of 2,670,000 shares.

How does Oncternal Therapeutics' short interest compare to its competitors?

0.63% of Oncternal Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Oncternal Therapeutics: Indaptus Therapeutics, Inc. (1.71%), CytoMed Therapeutics Limited (0.89%), Iterum Therapeutics plc (9.40%), Bullfrog AI Holdings, Inc. (6.78%), Lisata Therapeutics, Inc. (0.25%), Addex Therapeutics Ltd (0.85%), NeuroSense Therapeutics Ltd. (0.70%), DURECT Co. (3.55%), Biora Therapeutics, Inc. (4.16%), Cumberland Pharmaceuticals Inc. (0.21%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks.

What does it mean to sell short Oncternal Therapeutics stock?

Short selling ONCT is an investing strategy that aims to generate trading profit from Oncternal Therapeutics as its price is falling. ONCT shares are trading down $0.31 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Oncternal Therapeutics?

A short squeeze for Oncternal Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ONCT, which in turn drives the price of the stock up even further.

How often is Oncternal Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ONCT, twice per month. The most recent reporting period available is March, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:ONCT) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners